23andMe was founded in 2006 as a direct-to-consumer genetics testing specialist and became a publicly traded company in June 2021, trading under the ticker symbol «ME.» At.
What just happened? DNA testing specialist 23andMe has filed for Chapter 11 bankruptcy protection in order to facilitate a sale. Mark Jensen, chair and member of the special committee of the board of directors, said that after a thorough evaluation, it was decided that a court-supervised sale process would be the best path forward to maximize the value of the business.
23andMe was founded in 2006 as a direct-to-consumer genetics testing specialist and became a publicly traded company in June 2021, trading under the ticker symbol «ME.» At the time, co-founder and CEO Anne Wojcicki said the company had over 11 million users that were using genetics to transform how they diagnose, treat, and prevent human disease.
